Jagsonpal Pharmaceuticals Quarterly Results for Trading Insights
JAGSNPHARM • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹55 Cr
QMarch 2025
Jagsonpal Pharmaceuticals Quarterly Results Key Highlights
- Revenue of ₹277 Cr in March 2025 (+0.0% vs March 2025, +27.1% vs March 2024)
- Net Profit of ₹55 Cr in March 2025 (+0.0% vs March 2025, +139.1% vs March 2024)
- EBITDA of ₹59 Cr in March 2025 (+0.0% vs March 2025)
- Operating Margin of 19.0% in March 2025 (+0.0pp vs March 2025)
- Earnings Per Share of ₹8.26 in March 2025 (+0.0% vs March 2025)
Jagsonpal Pharmaceuticals Quarterly Results Analysis
| Metric | 2026 | March 2025 | March 2024 | March 2023 | March 2022 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 317 | 277 | 218 | 242 | 221 | 14.4% | - |
| Net Profit (₹ Cr) | 62 | 55 | 23 | 27 | 19 | - | - |
| EBITDA (₹ Cr) | 89 | 59 | 32 | 40 | 29 | - | - |
| EPS (₹) | 9.20 | 8.26 | 8.49 | 10.20 | 7.20 | - | - |
| Operating Margin (%) | 19.0% | 19.0% | 11.0% | 14.0% | 12.0% | - | - |
Jagsonpal Pharmaceuticals Share Price Trend Around Quarterly Results
Visualize Jagsonpal Pharmaceuticals's 1-year price movement across quarterly results — ideal for logging trades in Jagsonpal Pharmaceuticals share price
chart using Tickjournal. All values in ₹.
Related Pages for Jagsonpal Pharmaceuticals
Additional stock information and data for JAGSNPHARM
Revenue Trend (₹ Cr)
March 2023
242
March 2024
218
March 2025
277
2026
317
Net Profit Trend (₹ Cr)
March 2023
27
March 2024
23
March 2025
55
2026
62
Operating Margin Trend (%)
March 2023
14.0%
March 2024
11.0%
March 2025
19.0%
2026
19.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Jagsonpal Pharmaceuticals quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹422,330.94 Cr | 1760.2 | 14,875 | 3,125 | +10.8% | - | 21.0% | 135.4 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6642.5 | 2,860 | 689 | +7.1% | - | 24.1% | 255.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 3936.8 | 3,219 | 591 | +11.3% | - | 18.4% | 224.4 |
|
Cipla
Sept 2025 |
₹121,238.47 Cr | 1530.8 | 7,716 | 1,353 | +12.0% | - | 17.5% | 91.5 |
|
Dr Reddys Laborator…
Sept 2025 |
₹104,829.57 Cr | 1256.2 | 9,135 | 1,337 | +1.1% | - | 14.6% | 77.6 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores